Send to

Choose Destination
BMJ. 2018 Sep 24;362:k3694. doi: 10.1136/bmj.k3694.

Challenges of independent assessment of potential harms of HPV vaccines.

Author information

Nordic Cochrane Centre, Rigshospitalet, Copenhagen, Denmark.
University of Maryland School of Pharmacy, Baltimore, Maryland, USA.
[Indexed for MEDLINE]

Conflict of interest statement

Competing interests: We have read and understood BMJ policy on declaration of interests and declare the following interests. PD and TJ are recipients of a grant from the Laura and John Arnold Foundation to run a RIAT Support Center and were corecipients of a UK National Institute for Health Research grant (HTA–10/80/01 Update and amalgamation of two Cochrane reviews: neuraminidase inhibitors for preventing and treating influenza in healthy adults and children). They are also in receipt of a Cochrane Methods Innovations Fund grant to develop guidance on the use of regulatory data in Cochrane reviews. PD sued the attorney general of Canada to get access to data on HPV vaccines. He has received funding from the American Association of Colleges of Pharmacy for a study to analyse written medical information on the possible harms of statins. PD is also an associate editor of The BMJ and an unpaid member of the IMEDS steering committee at the Reagan-Udall Foundation for the FDA, which focuses on drug safety research. TJ is occasionally interviewed by market research companies about phase I or II drugs. He has acted as an expert witness in litigation cases related to the antiviral oseltamivir and influenza vaccines and been a scientific adviser to a legal team acting on oseltamivir. TJ was a member of three advisory boards for Boerhinger Ingelheim and a member of an independent data monitoring committee for a Sanofi Pasteur clinical trial of an influenza vaccine. From 1994 to 2013, TJ was the coordinator of the Cochrane Vaccines Field. He is coholder of a Jean Monnet Network Grant. He is an unpaid collaborator to the project Beyond Transparency in Pharmaceutical Research and Regulation led by Dalhousie University and funded by the Canadian Institutes of Health Research. LJ and PCG have no competing interests to declare.

Supplemental Content

Full text links

Icon for HighWire
Loading ...
Support Center